Azafaros to Present at J.P. Morgan Healthcare Conference
09 Jan 2025 //
BUSINESSWIRE
Azafaros Gets Regulatory Clearance For 2025 Global Phase 3 Studies
08 Jan 2025 //
BUSINESSWIRE
Positive Nizubaglustat Phase 2 Data Presented For NPC And GM2
10 Sep 2024 //
BUSINESSWIRE
Azafaros Reports Positive Phase 2 Data For Nizubaglustat In GM2 And NPC
16 Jul 2024 //
BUSINESSWIRE